Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Oral administration of lipid oil-in-water emulsions performed with synthetic or protein-type emulsifiers differentially affects post-prandial triacylglycerolemia in rats.
Nassra M, Bourgeois C, Subirade M, Sauvant P, Atgié C.
J Physiol Biochem. 2018 Nov;74(4):603-612. doi: 10.1007/s13105-018-0634-0. Epub 2018 May 3.
Similar articles
High volume of polysorbate-containing (Tween® 80) solutions induces false-positive results in intradermal test.
Wagner N, Podda M.
J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1972-1976. doi: 10.1111/jdv.14999. Epub 2018 Jun 13.
Xolair-induced recurrent anaphylaxis through sensitization to the excipient polysorbate.
Perino E, Freymond N, Devouassoux G, Nicolas JF, Berard F.
Ann Allergy Asthma Immunol. 2018 Jun;120(6):664-666. doi: 10.1016/j.anai.2018.02.018. Epub 2018 Feb 23. No abstract available.
First report of allergic contact dermatitis caused by sorbitan caprylate.
Vandeweghe J, Decoster E, Lapeere H.
Contact Dermatitis. 2018 Feb;78(2):162-164. doi: 10.1111/cod.12876. No abstract available.
[Indirect identification of hypersensitivity reaction to etoposide mediated by polysorbate 80].
Pantín C, Letellez J, Calzas J, Mohedano E.
Farm Hosp. 2018 Jan 1;42(1):27-28. doi: 10.7399/fh.10882. Spanish. No abstract available.
Comparison of the Local Tolerability to 5 Long-acting Drug Nanosuspensions with Different Stabilizing Excipients, Following a Single Intramuscular Administration in the Rat.
Chamanza R, Darville N, van Heerden M, De Jonghe S.
Toxicol Pathol. 2018 Jan;46(1):85-100. doi: 10.1177/0192623317737295. Epub 2017 Nov 2.
Evaluation of a primary course of H9N2 vaccine with or without AS03 adjuvant in adults: A phase I/II randomized trial.
Madan A, Collins H, Sheldon E, Frenette L, Chu L, Friel D, Drame M, Vaughn DW, Innis BL, Schuind A.
Vaccine. 2017 Aug 16;35(35 Pt B):4621-4628. doi: 10.1016/j.vaccine.2017.07.013. Epub 2017 Jul 15.
Adjuvanted (AS03) A/H1N1 2009 Pandemic Influenza Vaccines and Solid Organ Transplant Rejection: Systematic Signal Evaluation and Lessons Learnt.
Dos Santos G, Seifert HA, Bauchau V, Shinde V, Barbeau DM, Cohet C.
Drug Saf. 2017 Aug;40(8):693-702. doi: 10.1007/s40264-017-0532-3.
Design and in vivo evaluation of solid lipid nanoparticulate systems of Olanzapine for acute phase schizophrenia treatment: Investigations on antipsychotic potential and adverse effects.
Joseph E, Reddi S, Rinwa V, Balwani G, Saha R.
Eur J Pharm Sci. 2017 Jun 15;104:315-325. doi: 10.1016/j.ejps.2017.03.050. Epub 2017 Apr 11.
Anaphylaxis Due to the Excipient Polysorbate 80.
Palacios Castaño MI, Venturini Díaz M, Lobera Labairu T, González Mahave I, Del Pozo Gil MD, Blasco Sarramián A.
J Investig Allergol Clin Immunol. 2016;26(6):394-396. doi: 10.18176/jiaci.0109. No abstract available.
Evaluation of anaphylactoid constituents in vitro and in vivo.
Xu Y, Liu C, Dou D, Wang Q.
Int Immunopharmacol. 2017 Feb;43:79-84. doi: 10.1016/j.intimp.2016.12.010. Epub 2016 Dec 13.
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine and an MF59-adjuvanted influenza vaccine after concomitant vaccination in ⩾60-year-old adults.
Song JY, Cheong HJ, Hyun HJ, Seo YB, Lee J, Wie SH, Choi MJ, Choi WS, Noh JY, Yun JW, Yun JG, Kim WJ.
Vaccine. 2017 Jan 5;35(2):313-320. doi: 10.1016/j.vaccine.2016.11.047. Epub 2016 Dec 3.
Chitosan nanoparticles and their Tween 80 modified counterparts disrupt the developmental profile of zebrafish embryos.
Yuan Z, Li Y, Hu Y, You J, Higashisaka K, Nagano K, Tsutsumi Y, Gao J.
Int J Pharm. 2016 Dec 30;515(1-2):644-656. doi: 10.1016/j.ijpharm.2016.10.071. Epub 2016 Nov 5.
Skin penetration and dermal tolerability of acrylic nanocapsules: Influence of the surface charge and a chitosan gel used as vehicle.
Contri RV, Fiel LA, Alnasif N, Pohlmann AR, Guterres SS, Schäfer-Korting M.
Int J Pharm. 2016 Jun 30;507(1-2):12-20. doi: 10.1016/j.ijpharm.2016.03.046. Epub 2016 Apr 26.
A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among children.
Stassijns J, Bollaerts K, Baay M, Verstraeten T.
Vaccine. 2016 Feb 3;34(6):714-22. doi: 10.1016/j.vaccine.2015.12.024. Epub 2015 Dec 28. Review.
Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial.
Bernstein DI, Munoz FM, Callahan ST, Rupp R, Wootton SH, Edwards KM, Turley CB, Stanberry LR, Patel SM, Mcneal MM, Pichon S, Amegashie C, Bellamy AR.
Vaccine. 2016 Jan 12;34(3):313-9. doi: 10.1016/j.vaccine.2015.11.056. Epub 2015 Dec 2.
Assessment of Prime-boost Vaccination Using an AS03B-adjuvanted Influenza A (H5N1) Vaccine: A Randomized Trial in Children of Three to Less Than Eighteen Years of Age.
Izurieta P, Uy-Aragon MJ, Dramé M, Vaughn DW.
Pediatr Infect Dis J. 2016 Feb;35(2):e35-47. doi: 10.1097/INF.0000000000000968.
Randomized Controlled Trial of Adjuvanted Versus Nonadjuvanted Influenza Vaccine in Kidney Transplant Recipients.
Kumar D, Campbell P, Hoschler K, Hidalgo L, Al-Dabbagh M, Wilson L, Humar A.
Transplantation. 2016 Mar;100(3):662-9. doi: 10.1097/TP.0000000000000861.
Risk assessment of supply chain for pharmaceutical excipients with AHP-fuzzy comprehensive evaluation.
Li M, Du Y, Wang Q, Sun C, Ling X, Yu B, Tu J, Xiong Y.
Drug Dev Ind Pharm. 2016;42(4):676-84. doi: 10.3109/03639045.2015.1075027. Epub 2015 Aug 12.
Drug Dev Ind Pharm. 2016 Apr;42(4):676-684. Epub 2015 Aug 12.
Filters: Manage Filters